arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Quanterix Corp

QTRX
$3.17 ▼ -0.01 (-0.31%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
39 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Quanterix Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $149.5M
Dividend Yield —
Revenue Growth 34.4% ↗
Op. Margin -150.2% ↘
ROIC -20.8% ↘
FCF / Share $-0.11 ↗
Trailing P/E —
Price / Book 0.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

39-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$32.91M
↑ +34.4% —
Net Income Profit after all expenses
$-17.54M
↑ +14.5% —
Operating Margin Operating profit as % of sales
-150.2%
↓ -32.3% 3th
FCF / Share Free cash flow per share
$-0.11
↑ +71.5% —
Long-Term Debt Long-term obligations
$1.94M
↓ -74.7% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
3
Returns ↓
20
Cash Quality ↓
51

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 39 quarters